CE
NASDAQ · CERE
Cerevel Therapeutics Holdings, Inc.
Healthcare · Biotechnology
$44.96
Up+$0.33 (+0.74%)
Updated Oct 7, 2026, 12:40 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 8.19B
- P/E ratio
- -16.83
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 15.03M
- Avg. volume
- 2.11M
Price performance · CERE
CERE price history
1M range · 0 trading sessions · Daily adjusted prices
CERE does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest CERE news
The latest Smart Investors Daily articles mentioning CERE.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News
Loading stock research…
